|
Volumn 37, Issue 9, 2011, Pages 1560-
|
Gut overgrowth harms the critically ill
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CEFOTAXIME;
CEFTAZIDIME;
CIPROFLOXACIN;
PIPERACILLIN PLUS TAZOBACTAM;
POLYENE ANTIBIOTIC AGENT;
POLYMYXIN;
PROBIOTIC AGENT;
TOBRAMYCIN;
VANCOMYCIN;
AEROBIC BACTERIUM;
ANTIBIOTIC RESISTANCE;
BACTERIAL OVERGROWTH;
BACTERIUM ISOLATE;
CANDIDA;
CRITICALLY ILL PATIENT;
DIGESTIVE TRACT SECRETION;
ENTEROPATHY;
ESCHERICHIA COLI;
GUT OVERGROWTH;
HAEMOPHILUS INFLUENZAE;
HUMAN;
INTENSIVE CARE;
LETTER;
META ANALYSIS (TOPIC);
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MORTALITY;
NONHUMAN;
PROPHYLAXIS;
PSEUDOMONAS AERUGINOSA;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PNEUMONIAE;
ANTI-BACTERIAL AGENTS;
CROSS INFECTION;
FEMALE;
GASTROINTESTINAL TRACT;
HUMANS;
MALE;
PROBIOTICS;
|
EID: 80054753139
PISSN: 03424642
EISSN: 14321238
Source Type: Journal
DOI: 10.1007/s00134-011-2287-0 Document Type: Letter |
Times cited : (7)
|
References (5)
|